A detailed history of Kovitz Investment Group Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 18,747 shares of NVS stock, worth $1.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,747
Previous 20,741 9.61%
Holding current value
$1.95 Million
Previous $2.21 Million 2.36%
% of portfolio
0.01%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $211,623 - $241,054
-1,994 Reduced 9.61%
18,747 $2.16 Million
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $633,549 - $734,840
6,844 Added 49.25%
20,741 $2.21 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $886,773 - $1.01 Million
9,308 Added 202.83%
13,897 $1.34 Million
Q3 2023

Nov 09, 2023

SELL
$94.73 - $105.13 $12,788 - $14,192
-135 Reduced 2.86%
4,589 $467,000
Q2 2023

Aug 08, 2023

SELL
$92.52 - $104.91 $105,472 - $119,597
-1,140 Reduced 19.44%
4,724 $476,000
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $50,018 - $58,006
-625 Reduced 9.63%
5,864 $539,000
Q4 2022

Jan 19, 2023

SELL
$75.55 - $92.52 $12,541 - $15,358
-166 Reduced 2.49%
6,489 $589,000
Q3 2022

Nov 09, 2022

SELL
$74.61 - $87.26 $7,461 - $8,726
-100 Reduced 1.48%
6,655 $506,000
Q2 2022

Aug 02, 2022

SELL
$80.52 - $93.75 $7,407 - $8,625
-92 Reduced 1.34%
6,755 $571,000
Q1 2022

Apr 22, 2022

SELL
$80.11 - $90.62 $140,432 - $158,856
-1,753 Reduced 20.38%
6,847 $601,000
Q4 2021

Feb 04, 2022

BUY
$79.7 - $88.13 $26,540 - $29,347
333 Added 4.03%
8,600 $812,000
Q3 2021

Oct 28, 2021

SELL
$81.78 - $95.14 $17,173 - $19,979
-210 Reduced 2.48%
8,267 $676,000
Q2 2021

Aug 04, 2021

SELL
$85.24 - $94.15 $33,243 - $36,718
-390 Reduced 4.4%
8,477 $773,000
Q1 2021

May 06, 2021

BUY
$83.5 - $98.47 $38,994 - $45,985
467 Added 5.56%
8,867 $758,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $39,035 - $47,215
-500 Reduced 5.62%
8,400 $793,000
Q3 2020

Nov 10, 2020

SELL
$82.14 - $91.0 $58,319 - $64,610
-710 Reduced 7.39%
8,900 $774,000
Q2 2020

Aug 12, 2020

SELL
$80.93 - $91.1 $121,880 - $137,196
-1,506 Reduced 13.55%
9,610 $839,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $20,918 - $29,306
-296 Reduced 2.59%
11,116 $916,000
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $4,217 - $4,768
50 Added 0.44%
11,412 $1.08 Million
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $17,108 - $18,852
-200 Reduced 1.73%
11,362 $988,000
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $18,171 - $22,364
-241 Reduced 2.04%
11,562 $1.06 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $889,001 - $1.02 Million
11,803 New
11,803 $1.14 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.